Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.31 (
beta-glucuronidase
)
7,680
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Colon
tumors induced with azoxymethane in male Fischer rats were cytochemically analyzed for
beta-glucuronidase
using naphthol AS-B1 glucuronide (6-bromo-2-hydroxy-3-naphthoyl-O-anisidine) as a substrate and hexazonium pararosanin as a diazo reagent. This method effectively localizes the bulk of
beta-glucuronidase
in the surface epithelium, the lamina propria and in the endothelial cells of the lymphoid sinuses and postcapillary venules. Polypoid lesions, adenocarcinomas and mucinous adenocarcinomas show no difference in the amount or in the localization of
beta-glucuronidase
; however, mucinous adenocarcinomas show a slight increase in the amount of
beta-glucuronidase
. The few tumors that did metastasize to lymph nodes did not show any difference in their enzyme patterns. Intestinal crypts that show a change in size and shape have a definite increase in
beta-glucuronidase
activity. An increase in the activity of this enzyme can also be seen in well defined neoplasms as opposed to normal areas of the colon.
...
PMID:The cytochemical demonstration of beta-glucuronidase in colon neoplasms of rats exposed to azoxymethane. 62 76
The effect of a new prostacyclin analogue OP-41483 on ischemic colonic anastomosis was investigated in dogs. Colonic ischemia was produced by devascularization of the marginal vessels in the left colon and graded into three degrees by measuring colonic blood flow with a hydrogen gas clearance method. The agent was administered intravenously after devascularization using a continuous infusion pump. The parameters studied were colonic blood flow in the submucosal layer, rate of anastomotic leakage,
beta-glucuronidase
activity and protein content of the colonic mucosa, and histologic changes. After administration of the agent, blood flow increased significantly and
beta-glucuronidase
activity at the anastomotic site was well preserved at a relatively high level in spite of ischemic change. The anastomotic leakage rate was significantly decreased. The present study proved that administration of this new prostacyclin analogue minimizes ischemic damage, and may be of considerable importance in ischemic colonic anastomoses.
Dis
Colon
Rectum 1988 Jul
PMID:Effect of a new prostacyclin analogue on anastomosis of ischemic colon in dogs. 329 62
In one experiment Swiss mice were maintained on a 16 or 23% fat diet (laboratory chow with added fat, principally corn oil) or on laboratory chow alone (5.5% fat). In another experiment C57BL/1 mice were given a 23% fat diet (as above) or a low-fat diet (67% laboratory chow, 1.9% corn oil, and 31% starch; 5.5% fat).
Colon
mucosal samples were analyzed for several enzyme activities. In Swiss mice the analyses revealed the following: 1) Ouabain-insensitive ATPase was unaltered in male mice, but it rose significantly in females fed a high-fat diet (this effect was seen when a resuspended high-speed pellet was analyzed but not seen with the initial homogenate); 2) 5'-nucleotidase activity showed a significant stepwise increase with dietary fat; 3) nonspecific esterase activity tended to rise with a high-fat diet (not significant); 4)
beta-glucuronidase
levels were not altered by diet fat; and 5) ornithine decarboxylase levels were not altered by diet fat. In C57BL/1 mice analyses were done on ouabain-insensitive ATPase, 5'-nucleotidase, nonspecific esterase, and
beta-glucuronidase
, but no diet effects were seen. Fecal reductase activity was measured with the use of 2-(p-iodophenyl)-3-(p-nitrophenyl)-5-phenyltetrazolium chloride hydrate). A high-fat diet did not affect the activity in C57BL/1 mice, but it caused a significant rise in Swiss mice.
...
PMID:High-fat diets and fecal level of reductase and colon mucosal level of ornithine decarboxylase, beta-glucuronidase, 5'-nucleotidase, ATPase, and esterase in mice. 632 44
Multiprotein bridging factor 1 (MBF1) is a transcriptional co-activator that mediates transcriptional activation by bridging between an activator and a TATA-box binding protein (TBP). Recently, we have reported that three Arabidopsis MBF1s play roles as transcriptional co-activators. This study shows that AtMBF1c is totally different from the other two in its structure and expression pattern, and that MBF1c genes also occur in other plant species, including monocots. We performed histochemical analysis of these genes using
beta-glucuronidase
(GUS) assays to characterize the expression profile of each AtMBF1 gene extensively. In pAtMBF1a
Colon
, two colons GUS transformants, GUS staining was observed only in anthers and seeds, whereas strong GUS activity in pAtMBF1b
Colon
, two colons GUS transformants was detected in leaf veins, stems, anthers, and seeds. In mature pAtMBF1c
Colon
, two colons GUS transformants, GUS staining was observed in almost all tissues. It is noteworthy that intense GUS staining was observed in anthers of all transformants. We also found that AtMBF1c expression was up-regulated upon diverse stress treatments including exposure to heat, hydrogen peroxide, dehydration, and high concentrations of salt. These findings suggest that AtMBF1c may be involved in stress response pathway.
...
PMID:Structure and expression analysis of three subtypes of Arabidopsis MBF1 genes. 1545 Nov 67